Haemonetics
This article was originally published in The Gray Sheet
Executive Summary
Maker of automated blood processing systems says it will acquire the remaining 80% of Transfusion Technologies Corp. not already owned. The cash deal was announced Sept. 5. Haemonetics will gain Tranfusion Technologies' orthopedic perioperative autotransfusion system OrthoPat, which incorporates Dynamic Disc centrifuge technology, as well as access to the Chairside Separator, an automated whole blood collection device in late-stage development. The Dynamic Disk centrifuge system "has tremendous synergy with Haemonetics' core product line and a very promising marketing potential," the firm says. Last November, Haemonetics bought about 20% of TTC for $15 mil